Medical News

RSS

Mental illness associated with more lost work days than any other chronic condition: Study

With mental illness associated with more lost work days than any other chronic condition and costing $17.7 billion annually in lost productivity, understanding its underpinnings is increasingly important to the Canadian economy. Now new research from the Centre for Addiction and Mental Health (CAMH) indicates that the strongest predictor for work disability leaves is a person's past history of occurrences.

18 Feb 2010

AMRI announces Excelsyn acquisition

AMRI today announced the acquisition of Excelsyn Ltd., a well recognized leader in providing chemical development and manufacturing services to the pharmaceutical industry in Europe. Located in Holywell, North Wales, UK, Excelsyn has 60 employees and generated revenue of $15 million in 2009.

18 Feb 2010

HealthTrust Purchasing Group signs 3-year vascular graft procurement contract with MAQUET Cardiovascular

MAQUET Cardiovascular, LLC, a leading provider of cardiovascular technologies, announced today that it has signed a three year contract with HealthTrust Purchasing Group, LP to provide woven and knitted textile vascular grafts to the HealthTrust membership. The contract includes the HEMASHIELD product line and other vascular grafts, which are used to surgically repair or replace damaged blood vessels, including the aorta.

18 Feb 2010

Raysearch Laboratories reports net sales of SEK 83.7M in 2009

“The year 2009 was extremely successful for RaySearch, with several exciting product launches. The new products began generating substantial revenues toward the end of the year, leading to a revenue increase of a full 71 percent in the fourth quarter”

18 Feb 2010

Nanotechnology plays a key role in detection and treatment of cancer

A world-renowned medical researcher discusses the key role that nanotechnology has begun to play in the detection and treatment of cancer in an article that will appear in the March 2010 edition of Mechanical Engineering magazine.

18 Feb 2010

Catalyst Pharmaceutical Partners to present overview of CPP-115 compound at epilepsy conference

Catalyst Pharmaceutical Partners, Inc. announced today that it was selected by both the Scientific and Business Advisory Boards of the Epilepsy Therapy Project to present at the 2010 Epilepsy Pipeline Update Conference, an in-depth, two day forum to be held February 25-26, 2010, at the Hyatt Embarcadero Hotel in San Francisco.

18 Feb 2010

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.

18 Feb 2010

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

In a new study of treatment-experienced HIV-1-infected adults with no PREZISTA® (darunavir) resistance-associated mutations (RAMs), 72 percent of patients in the PREZISTA/ritonavir (r) (800/100 mg) once-daily arm achieved undetectable viral loads (<50 copies/mL) compared with 71 percent of patients in the PREZISTA/r (600/100 mg) twice-daily arm. The study met its primary objective of non-inferiority. These data from the Phase 3b ODIN study were presented today at CROI 2010, the 17th Conference on Retroviruses and Opportunistic Infections, in San Francisco.

18 Feb 2010

Researchers discover new prognosis marker for prostate cancer

Measuring levels of the active form of the protein EGFR in the tumor and its vicinity can provide a more reliable prognosis for individuals with prostate cancer.

18 Feb 2010

Aptuit develops proprietary production screen to understand API and drug formulations

Aptuit, Inc., today announced that it has developed a proprietary production screen to enable a better understanding of active pharmaceutical ingredients (API) and drug formulations earlier in the product lifecycle. The production screen applies advanced theoretical developments in solid-state chemistry to address challenges at the most critical interfaces in the drug development process.

18 Feb 2010

Anesthesiologists warn patients to do more research before opting for elective medical procedures

Headlines littered with patient friendly terms such as "no general anesthesia," "lunchtime lipo," and "no scar" may have some cash and time strapped patients considering an elective surgical procedure.

18 Feb 2010

Sonova Holding AG anticipates organic sales growth of 17-18% for business year 2009/10

Sonova Holding AG, the world’s leading provider of hearing systems, announced today, that the Group anticipates an organic sales growth of 17-18% and an EBITA margin of around 28% for the business year 2009/10 - barring unforeseen events.

18 Feb 2010

Rondaxe and TD2 announce cancer drug development alliance

TGen Drug Development (TD2) and Rondaxe Enterprises today announced a strategic alliance that will help emerging companies speed new high-quality treatments to cancer patients.

18 Feb 2010

GSK Consumer Healthcare applauds two smoking cessation organizations for improving smoking cessation aids

GlaxoSmithKline Consumer Healthcare, marketer of nicotine replacement therapy (NRT) products, including Nicorette®, NicoDerm® CQ® and Commit®, applauds two leading smoking cessation organizations for their efforts to improve the regulation of smoking cessation aids designed to help people quit smoking.

18 Feb 2010

New IPI publication outlines effective healthcare reform plan

President Obama's call during the State of the Union address for a better approach to health care reform is answered today with the release of a new publication from the Institute for Policy Innovation (IPI) entitled, "Health Care Reform: What Now?"

18 Feb 2010

US health plans adopt unified approach to assist consumers in appropriate medication use

Dozens of US health plans nationwide have adopted a unified approach to assist seniors and other consumers to appropriately use medications. The move follows increased emphasis from the federal government for Medicare plans to offer more robust Medication Therapy Management (“MTM”) programs in 2010.

18 Feb 2010

NCI's NCL to conduct characterization studies of Celator Pharmaceuticals' HDPN formulation

Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.

18 Feb 2010

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

18 Feb 2010

Study: Telenurses face complex decision-making processes when dealing with calls

Nurses who provide telephone advice services have to balance the conflicting demands of providing appropriate medical advice and acting as a gatekeeper to limited healthcare services, according to a review in the March issue of the Journal of Advanced Nursing.

18 Feb 2010

Senior citizens urge Congress to start over on healthcare reform

With President Obama hosting a bipartisan meeting on health care reform next week, the 60 Plus Association announced today a new advertising campaign featuring seniors who urge Congress to "Start over and get health care right."

18 Feb 2010

Medical News

Mental illness associated with more lost work days than any other chronic condition: Study

AMRI announces Excelsyn acquisition

HealthTrust Purchasing Group signs 3-year vascular graft procurement contract with MAQUET Cardiovascular

Raysearch Laboratories reports net sales of SEK 83.7M in 2009

Nanotechnology plays a key role in detection and treatment of cancer

Catalyst Pharmaceutical Partners to present overview of CPP-115 compound at epilepsy conference

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Researchers discover new prognosis marker for prostate cancer

Aptuit develops proprietary production screen to understand API and drug formulations

Anesthesiologists warn patients to do more research before opting for elective medical procedures

Sonova Holding AG anticipates organic sales growth of 17-18% for business year 2009/10

Rondaxe and TD2 announce cancer drug development alliance

GSK Consumer Healthcare applauds two smoking cessation organizations for improving smoking cessation aids

New IPI publication outlines effective healthcare reform plan

US health plans adopt unified approach to assist consumers in appropriate medication use

NCI's NCL to conduct characterization studies of Celator Pharmaceuticals' HDPN formulation

Sorin Group's newest generation C5 HLM system receives FDA clearance

Study: Telenurses face complex decision-making processes when dealing with calls

Senior citizens urge Congress to start over on healthcare reform

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News